Enanta Pharmaceuticals
ENTA
ENTA
136 hedge funds and large institutions have $347M invested in Enanta Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 52 increasing their positions, 38 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
17% more capital invested
Capital invested by funds: $296M → $347M (+$50.7M)
5% more funds holding
Funds holding: 129 → 136 (+7)
Holders
136
Holding in Top 10
3
Calls
$554K
Puts
$221K
Top Buyers
| 1 | +$14.6M | |
| 2 | +$9.25M | |
| 3 | +$6.71M | |
| 4 |
GTC
Ghost Tree Capital
New York
|
+$6.65M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$6.44M |
Top Sellers
| 1 | -$22.1M | |
| 2 | -$12.5M | |
| 3 | -$8.54M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$8.54M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$7.69M |